IDIVX
Price
$19.27
Change
-$0.52 (-2.63%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

IDIVX vs RMFCX

Header iconIDIVX vs RMFCX Comparison
Open Charts IDIVX vs RMFCXBanner chart's image
Integrity Dividend Harvest A
Price$19.27
Change-$0.52 (-2.63%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
IDIVX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IDIVX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDIVX is a Buy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. IDIVX (425M). IDIVX pays higher dividends than RMFCX: IDIVX (2.96) vs RMFCX (1.69). IDIVX was incepted earlier than RMFCX: IDIVX (13 years) vs RMFCX (23 years). RMFCX is a more actively managed with annual turnover of: 25.00 vs. IDIVX (22.79). RMFCX has a lower initial minimum investment than IDIVX: RMFCX (250) vs IDIVX (1000). IDIVX annual gain was more profitable for investors over the last year : 23.55 vs. RMFCX (12.63). IDIVX return over 5 years is better than : 55.23 vs. RMFCX (40.39).
IDIVXRMFCXIDIVX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years23 years-
Gain YTD22.63311.423198%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets425M98.7B0%
Annual Yield % from dividends2.961.69175%
Returns for 1 year23.5512.63187%
Returns for 3 years34.2814.16242%
Returns for 5 years55.2340.39137%
Returns for 10 years99.9161.84162%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc